3 Takeaways From CFIUS' OK Of ChemChina-Syngenta Deal

By Benjamin Horney (August 23, 2016, 9:54 PM EDT) -- The Committee on Foreign Investment in the United States' approval of ChemChina's $43 billion acquisition of Syngenta is the largest-ever outbound Chinese acquisition, and experts say the green light bodes well for future deals that will have to be approved by the committee because CFIUS evaluates the merits of each deal without being influenced by outside factors....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!